Drug Shortage Report for BREVICON 0.5/35 TABLETS (21-DAY PACK)

Last updated on 2018-04-24 History
Report ID 42178
Drug Identification Number 02187086
Brand name BREVICON 0.5/35 TABLETS (21-DAY PACK)
Common or Proper name Brevicon
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) ETHINYL ESTRADIOL NORETHINDRONE
Strength(s) 0.035MG 0.5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 21's
ATC code G03AA
ATC description HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-04-02
Estimated end date
Actual end date 2018-04-23
Shortage status Resolved
Updated date 2018-04-24
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-03-07 English Compare
v2 2018-03-07 French Compare
v3 2018-03-07 French Compare
v4 2018-04-02 English Compare
v5 2018-04-02 French Compare
v6 2018-04-03 English Compare
v7 2018-04-23 English Compare
v8 2018-04-23 French Compare
v9 2018-04-24 English Compare

Showing 1 to 9 of 9